These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26080339)

  • 1. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.
    Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M
    JAMA; 2015 Jun; 313(23):2349-58. PubMed ID: 26080339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer.
    Meester RGS; Doubeni CA; Zauber AG; van Ballegooijen M; Corley DA; Lansdorp-Vogelaar I
    Int J Cancer; 2017 Dec; 141(11):2359-2367. PubMed ID: 28815573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
    JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer.
    Schottinger JE; Jensen CD; Ghai NR; Chubak J; Lee JK; Kamineni A; Halm EA; Sugg-Skinner C; Udaltsova N; Zhao WK; Ziebell RA; Contreras R; Kim EJ; Fireman BH; Quesenberry CP; Corley DA
    JAMA; 2022 Jun; 327(21):2114-2122. PubMed ID: 35670788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.
    Kaminski MF; Wieszczy P; Rupinski M; Wojciechowska U; Didkowska J; Kraszewska E; Kobiela J; Franczyk R; Rupinska M; Kocot B; Chaber-Ciopinska A; Pachlewski J; Polkowski M; Regula J
    Gastroenterology; 2017 Jul; 153(1):98-105. PubMed ID: 28428142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
    Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
    J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
    [No Abstract]   [Full Text] [Related]  

  • 9. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.
    Austin GL; Fennimore B; Ahnen DJ
    Am J Gastroenterol; 2013 Mar; 108(3):296-301. PubMed ID: 23208273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
    Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
    Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
    Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
    Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
    J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
    Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
    Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
    JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring.
    Kaltenbach T; Gawron A; Meyer CS; Gupta S; Shergill A; Dominitz JA; Soetikno RM; Nguyen-Vu T; A Whooley M; Kahi CJ
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1883-1889.e1. PubMed ID: 33618027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evaluation of Critical Factors for the Cost-Effectiveness of Real-Time Computer-Aided Detection: Sensitivity and Threshold Analyses Using a Microsimulation Model.
    Thiruvengadam NR; Coté GA; Gupta S; Rodrigues M; Schneider Y; Arain MA; Solaimani P; Serrao S; Kochman ML; Saumoy M
    Gastroenterology; 2023 May; 164(6):906-920. PubMed ID: 36736437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies.
    Penz D; Ferlitsch A; Waldmann E; Irina G; Daniel P; Asaturi A; Hinterberger A; Majcher B; Szymanska A; Trauner M; Ferlitsch M
    Gastrointest Endosc; 2020 Jan; 91(1):135-141. PubMed ID: 31499041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
    Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
    Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonneoplastic polypectomy during screening colonoscopy: the impact on polyp detection rate, adenoma detection rate, and overall cost.
    Atia MA; Patel NC; Ratuapli SK; Boroff ES; Crowell MD; Gurudu SR; Faigel DO; Leighton JA; Ramirez FC
    Gastrointest Endosc; 2015 Aug; 82(2):370-375.e1. PubMed ID: 25843614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.